Glen Harbor Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $442K | Buy |
4,592
+560
| +14% | +$53.9K | 0.01% | 743 |
|
|
2019
Q2 | $464K | Buy |
4,032
+252
| +7% | +$29K | 0.01% | 727 |
|
|
2019
Q1 | $445K | Sell |
3,780
-1,484
| -28% | -$175K | 0.01% | 718 |
|
|
2018
Q4 | $330K | Sell |
5,264
-3,864
| -42% | -$242K | 0.01% | 765 |
|
|
2018
Q3 | $647K | Buy |
9,128
+280
| +3% | +$19.8K | 0.01% | 611 |
|
|
2018
Q2 | $589K | Buy |
8,848
+952
| +12% | +$63.4K | 0.01% | 591 |
|
|
2018
Q1 | $516K | Buy |
+7,896
| New | +$516K | 0.01% | 624 |
|